{"id":59755,"date":"2024-02-28T06:15:08","date_gmt":"2024-02-28T06:15:08","guid":{"rendered":"https:\/\/medsname.com\/venpad-xr\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"venpad-xr","status":"publish","type":"product","link":"https:\/\/medsbase.com\/bg\/product\/venpad-xr\/","title":{"rendered":"Venpad XR"},"content":{"rendered":"

<\/p>\n

\n

⚡ Quick Answer — What is Venpad XR?<\/h3>\n
\n

Venpad XR<\/strong> \u0441\u044a\u0434\u044a\u0440\u0436\u0430 venlafaxine ER (37.5 \/ 75 \/ 150 mg ER)<\/strong> from a WHO-GMP certified manufacturer (Symbiosis Pharmaceuticals) — an SNRI<\/strong> with broad evidence in depression and anxiety-spectrum disorders. Standard start: 75 mg once daily<\/strong> with food; titrate to 150–225 mg\/day for full SNRI activity (max 375 mg in MDD, 225 mg in GAD\/social anxiety\/panic). Onset: 2–4 weeks. Below 150 mg the drug behaves mostly as an SSRI; norepinephrine reuptake inhibition appears at higher doses. Important<\/strong>: dose-dependent blood-pressure rise<\/strong> (BP must be monitored at > 225 mg). Has a severe discontinuation syndrome<\/strong> — mandatory taper. More dangerous in overdose than SSRIs (cardiac toxicity, seizures).<\/p>\n<\/div>\n

\n\u041a\u0430\u043a\u0432\u043e \u043f\u043e\u043b\u0443\u0447\u0430\u0432\u0430\u0442\u0435 \u0441 MedsBase:<\/strong> \u041f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u0438\u0442\u0435\u043b, \u0441\u0435\u0440\u0442\u0438\u0444\u0438\u0446\u0438\u0440\u0430\u043d \u043e\u0442 WHO-GMP \u00b7 \u0414\u0438\u0441\u043a\u0440\u0435\u0442\u043d\u0430 \u043e\u043f\u0430\u043a\u043e\u0432\u043a\u0430 \u00b7 \u0414\u043e\u0441\u0442\u0430\u0432\u043a\u0430 \u043f\u043e \u0446\u0435\u043b\u0438\u044f \u0441\u0432\u044f\u0442 \u00b7 \u041d\u0430\u0434 1400 \u043f\u043e\u0442\u0432\u044a\u0440\u0434\u0435\u043d\u0438 \u043e\u0442\u0437\u0438\u0432\u0430 \u043e\u0442 \u043a\u043b\u0438\u0435\u043d\u0442\u0438<\/a>\n<\/div>\n

\ud83d\udce6 \u0412\u0441\u044f\u043a\u0430 \u043f\u043e\u0440\u044a\u0447\u043a\u0430 \u0435 \u043f\u043e\u043a\u0440\u0438\u0442\u0430 \u043e\u0442 \u043d\u0430\u0448\u0430\u0442\u0430 \u041f\u043e\u043b\u0438\u0442\u0438\u043a\u0430 \u0437\u0430 \u043f\u043e\u0432\u0442\u043e\u0440\u043d\u0430 \u0438\u0437\u043f\u0440\u0430\u0442\u043a\u0430<\/strong><\/a> \u2014 \u0430\u043a\u043e \u0432\u0430\u0448\u0430\u0442\u0430 \u043f\u0440\u0430\u0442\u043a\u0430 \u043d\u0435 \u043f\u0440\u0438\u0441\u0442\u0438\u0433\u043d\u0435 \u0432 \u0440\u0430\u043c\u043a\u0438\u0442\u0435 \u043d\u0430 20 \u0440\u0430\u0431\u043e\u0442\u043d\u0438 \u0434\u043d\u0438, \u043d\u0438\u0435 \u044f \u0438\u0437\u043f\u0440\u0430\u0449\u0430\u043c\u0435 \u043e\u0442\u043d\u043e\u0432\u043e.<\/p>\n

\u0417\u0430\u0449\u043e \u0434\u0430 \u043f\u043e\u0440\u044a\u0447\u0432\u0430\u0442\u0435 \u043e\u0442 MedsBase<\/h3>\n

\u041d\u0430\u0448\u0438\u0442\u0435 \u0433\u0435\u043d\u0435\u0440\u0438\u0447\u043d\u0438 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0430 \u0441\u0435 \u0434\u043e\u0441\u0442\u0430\u0432\u044f\u0442 \u043e\u0442 \u043f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u0438\u0442\u0435\u043b\u0438, \u0441\u0435\u0440\u0442\u0438\u0444\u0438\u0446\u0438\u0440\u0430\u043d\u0438 \u043e\u0442 WHO-GMP, \u0438 \u0441\u0435 \u0438\u0437\u043f\u0440\u0430\u0449\u0430\u0442 \u043f\u043e \u0446\u0435\u043b\u0438\u044f \u0441\u0432\u044f\u0442 \u0432 \u0434\u0438\u0441\u043a\u0440\u0435\u0442\u043d\u0430, \u043e\u0431\u0438\u043a\u043d\u043e\u0432\u0435\u043d\u0430 \u043e\u043f\u0430\u043a\u043e\u0432\u043a\u0430 \u2014 \u0431\u0435\u0437 \u0438\u043c\u0435 \u043d\u0430 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e\u0442\u043e \u0432\u044a\u043d\u0448\u043d\u043e \u043d\u0430 \u043f\u0440\u0430\u0442\u043a\u0430\u0442\u0430. \u041f\u043b\u0430\u0449\u0430\u043d\u0438\u044f\u0442\u0430 \u0441 \u043a\u0430\u0440\u0442\u0430 \u0441\u0435 \u043e\u0431\u0440\u0430\u0431\u043e\u0442\u0432\u0430\u0442 \u0447\u0440\u0435\u0437 \u0440\u0435\u0433\u0443\u043b\u0438\u0440\u0430\u043d \u043f\u0440\u043e\u0446\u0435\u0441\u043e\u0440 (\u043e\u043f\u0438\u0441\u0430\u043d\u0438\u0435\u0442\u043e \u043d\u0430 \u0438\u0437\u0432\u043b\u0435\u0447\u0435\u043d\u0438\u0435\u0442\u043e \u0432\u043a\u043b\u044e\u0447\u0432\u0430 \u0440\u0435\u0433\u0443\u043b\u0438\u0440\u0430\u043d \u043f\u0440\u043e\u0446\u0435\u0441\u043e\u0440 \u0437\u0430 \u043f\u043b\u0430\u0449\u0430\u043d\u0435 \u0441 \u043a\u0430\u0440\u0442\u0430 \u2014 \u043d\u0438\u043a\u043e\u0433\u0430 \u201cMedsBase\u201d \u0438\u043b\u0438 \u0438\u043c\u0435 \u043d\u0430 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e). \u041f\u0440\u0438\u0435\u043c\u0430\u0442 \u0441\u0435 \u0441\u044a\u0449\u043e \u043a\u0440\u0438\u043f\u0442\u043e\u0432\u0430\u043b\u0443\u0442\u0438 \u0438 \u0431\u0430\u043d\u043a\u043e\u0432 \u043f\u0440\u0435\u0432\u043e\u0434 SEPA. \u0412\u0441\u044f\u043a\u0430 \u043f\u043e\u0440\u044a\u0447\u043a\u0430 \u0435 \u043f\u043e\u0434\u043a\u0440\u0435\u043f\u0435\u043d\u0430 \u043e\u0442 \u043d\u0430\u0448\u0430\u0442\u0430 \u043f\u043e\u043b\u0438\u0442\u0438\u043a\u0430 \u0437\u0430 \u0433\u0430\u0440\u0430\u043d\u0442\u0438\u0440\u0430\u043d\u043e \u043f\u0440\u0435\u0438\u0437\u043f\u0440\u0430\u0449\u0430\u043d\u0435.<\/p>\n<\/div>\n

\u0412\u0430\u0436\u043d\u043e \u2014 \u0442\u043e\u0432\u0430 \u043d\u0435 \u0435 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e \u0437\u0430 \u0441\u0438\u0442\u0443\u0430\u0442\u0438\u0432\u043d\u0430 \u0442\u0440\u0435\u0432\u043e\u0436\u043d\u043e\u0441\u0442.<\/strong> Venpad XR is a serotonin-norepinephrine reuptake inhibitor (SNRI)<\/strong>, \u043a\u043e\u0435\u0442\u043e \u0441\u0435 \u043f\u0440\u0435\u0434\u043f\u0438\u0441\u0432\u0430 \u0438 \u0442\u0438\u0442\u0440\u0438\u0440\u0430 \u0432 \u0442\u0435\u0447\u0435\u043d\u0438\u0435 \u043d\u0430 \u0441\u0435\u0434\u043c\u0438\u0446\u0438 \u043f\u0440\u0438 major depressive disorder (MDD), generalised anxiety disorder (GAD), social anxiety disorder, and panic disorder<\/strong>. \u0422\u043e \u043d\u0435 \u0435 \u043d\u0435<\/strong> \u043f\u043e\u0434\u0445\u043e\u0434\u044f\u0449\u043e \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e \u0437\u0430 \u043e\u0441\u0442\u0440\u0430, \u0441\u0432\u044a\u0440\u0437\u0430\u043d\u0430 \u0441 \u0438\u0437\u043f\u044a\u043b\u043d\u0435\u043d\u0438\u0435 \u0442\u0440\u0435\u0432\u043e\u0436\u043d\u043e\u0441\u0442 (\u043b\u0435\u0442\u0435\u043d\u0435, \u043f\u0443\u0431\u043b\u0438\u0447\u043d\u0438 \u0438\u0437\u043a\u0430\u0437\u0432\u0430\u043d\u0438\u044f, \u0438\u0437\u043f\u0438\u0442\u0438) \u2014 \u0437\u0430 \u0442\u0435\u0437\u0438 \u0441\u043b\u0443\u0447\u0430\u0438 \u0431\u0435\u0442\u0430-\u0431\u043b\u043e\u043a\u0430\u0442\u043e\u0440\u0438\u0442\u0435 (\u043f\u0440\u043e\u043f\u0440\u0430\u043d\u043e\u043b\u043e\u043b), \u0431\u0435\u043d\u0437\u043e\u0434\u0438\u0430\u0437\u0435\u043f\u0438\u043d\u0438\u0442\u0435 \u0438\u043b\u0438 \u0445\u0438\u0434\u0440\u0430\u043a\u0441\u0438\u0437\u0438\u043d\u044a\u0442 \u0441\u0430 \u043a\u043b\u0438\u043d\u0438\u0447\u043d\u043e \u043f\u043e\u0434\u0445\u043e\u0434\u044f\u0449\u0438. \u0410\u043a\u043e \u043d\u044f\u043c\u0430\u0442\u0435 \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u0446\u0438\u0440\u0430\u043d\u043e \u043d\u0430\u0441\u0442\u0440\u043e\u0435\u043d\u0447\u0435\u0441\u043a\u043e, \u0442\u0440\u0435\u0432\u043e\u0436\u043d\u043e \u0438\u043b\u0438 \u043f\u0441\u0438\u0445\u0438\u0430\u0442\u0440\u0438\u0447\u043d\u043e \u0440\u0430\u0437\u0441\u0442\u0440\u043e\u0439\u0441\u0442\u0432\u043e, \u043d\u0435 \u0437\u0430\u043f\u043e\u0447\u0432\u0430\u0439\u0442\u0435 \u043f\u0440\u0438\u0435\u043c \u043d\u0430 \u0442\u043e\u0432\u0430 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e.<\/div>\n
\u041f\u0440\u0435\u0434\u0443\u043f\u0440\u0435\u0436\u0434\u0435\u043d\u0438\u0435 \u043e\u0442 FDA \u2014 \u0440\u0438\u0441\u043a \u043e\u0442 \u0441\u0430\u043c\u043e\u0443\u0431\u0438\u0439\u0441\u0442\u0432\u0435\u043d\u0438 \u043c\u0438\u0441\u043b\u0438 \u0438 \u043f\u043e\u0432\u0435\u0434\u0435\u043d\u0438\u0435.<\/strong> \u0412\u0441\u0438\u0447\u043a\u0438 \u0430\u043d\u0442\u0438\u0434\u0435\u043f\u0440\u0435\u0441\u0430\u043d\u0442\u0438 \u043d\u043e\u0441\u044f\u0442 \u043f\u0440\u0435\u0434\u0443\u043f\u0440\u0435\u0436\u0434\u0435\u043d\u0438\u0435 \u043e\u0442 FDA \u0437\u0430 \u043f\u043e\u0432\u0438\u0448\u0435\u043d \u0440\u0438\u0441\u043a \u043e\u0442 \u0441\u0430\u043c\u043e\u0443\u0431\u0438\u0439\u0441\u0442\u0432\u0435\u043d\u0438 \u043c\u0438\u0441\u043b\u0438 \u0438 \u043f\u043e\u0432\u0435\u0434\u0435\u043d\u0438\u0435 \u043f\u0440\u0438 \u0434\u0435\u0446\u0430, \u044e\u043d\u043e\u0448\u0438 \u0438 \u043c\u043b\u0430\u0434\u0438 \u0432\u044a\u0437\u0440\u0430\u0441\u0442\u043d\u0438 \u043f\u043e\u0434 25 \u0433\u043e\u0434\u0438\u043d\u0438, \u043e\u0441\u043e\u0431\u0435\u043d\u043e \u043f\u0440\u0435\u0437 \u043f\u044a\u0440\u0432\u0438\u0442\u0435 \u0441\u0435\u0434\u043c\u0438\u0446\u0438 \u043d\u0430 \u043b\u0435\u0447\u0435\u043d\u0438\u0435 \u0438\u043b\u0438 \u0441\u043b\u0435\u0434 \u043f\u0440\u043e\u043c\u0435\u043d\u0438 \u0432 \u0434\u043e\u0437\u0430\u0442\u0430. \u0421\u0435\u043c\u0435\u0439\u043d\u0438\u0442\u0435 \u0447\u043b\u0435\u043d\u043e\u0432\u0435 \u0438 \u043b\u0435\u043a\u0430\u0440\u0438\u0442\u0435 \u0442\u0440\u044f\u0431\u0432\u0430 \u0434\u0430 \u043d\u0430\u0431\u043b\u044e\u0434\u0430\u0432\u0430\u0442 \u0432\u043d\u0438\u043c\u0430\u0442\u0435\u043b\u043d\u043e \u0437\u0430 \u0432\u043b\u043e\u0448\u0430\u0432\u0430\u043d\u0435 \u043d\u0430 \u043d\u0430\u0441\u0442\u0440\u043e\u0435\u043d\u0438\u0435\u0442\u043e, \u0432\u044a\u0437\u0431\u0443\u0434\u0430 \u0438\u043b\u0438 \u0441\u0430\u043c\u043e\u0443\u0431\u0438\u0439\u0441\u0442\u0432\u0435\u043d\u0438 \u043c\u0438\u0441\u043b\u0438 \u043f\u0440\u0438 \u0442\u0430\u0437\u0438 \u0432\u044a\u0437\u0440\u0430\u0441\u0442\u043e\u0432\u0430 \u0433\u0440\u0443\u043f\u0430.<\/div>\n

What Is Venpad XR?<\/h2>\n

Venpad XR is an oral extended-release tablet\/capsule of venlafaxine (37.5 \/ 75 \/ 150 mg ER)<\/strong> manufactured by Symbiosis Pharmaceuticals under WHO-GMP certification. Venlafaxine (US brand Effexor XR<\/strong>) is the prototype serotonin-norepinephrine reuptake inhibitor (SNRI)<\/strong>. It blocks both the serotonin transporter (SERT) at lower doses and the norepinephrine transporter (NET) at higher doses, producing a dose-dependent shift from SSRI-like to SNRI-like pharmacology.<\/p>\n

It is a first-line option in NICE and APA guidelines for major depression and is one of the most-evidenced antidepressants for generalised anxiety disorder.<\/p>\n

\u041e\u0434\u043e\u0431\u0440\u0435\u043d\u0438 \u043f\u043e\u043a\u0430\u0437\u0430\u043d\u0438\u044f<\/h2>\n
    \n
  • \u2014 \u0432\u043a\u043b\u044e\u0447\u0438\u0442\u0435\u043b\u043d\u043e \u0434\u0435\u043f\u0440\u0435\u0441\u0438\u044f, \u043a\u043e\u044f\u0442\u043e \u043d\u0435 \u0440\u0435\u0430\u0433\u0438\u0440\u0430 \u043d\u0430 \u0438\u043b\u0438 \u043d\u0435 \u0441\u0435 \u0442\u043e\u043b\u0435\u0440\u0438\u0440\u0430 \u043e\u0442 SSRIs<\/strong> — including treatment-resistant depression at higher doses<\/li>\n
  • \u0413\u0435\u043d\u0435\u0440\u0430\u043b\u0438\u0437\u0438\u0440\u0430\u043d\u043e \u0442\u0440\u0435\u0432\u043e\u0436\u043d\u043e \u0440\u0430\u0437\u0441\u0442\u0440\u043e\u0439\u0441\u0442\u0432\u043e (\u0413\u0422\u0420)<\/strong><\/li>\n
  • Social anxiety disorder (chronic \/ generalised)<\/strong><\/li>\n
  • \u041f\u0430\u043d\u0438\u043a\u043e\u0432\u0430 \u043a\u0440\u0438\u0437\u0430<\/strong> — with and without agoraphobia<\/li>\n
  • Off-label: diabetic neuropathy, chronic fatigue, fibromyalgia, vasomotor symptoms of menopause<\/li>\n<\/ul>\n

    \u0414\u043e\u0437\u0438\u0440\u0430\u043d\u0435<\/h2>\n\n\n\n\n\n\n\n
    \u041f\u043e\u043a\u0430\u0437\u0430\u043d\u0438\u0435<\/th>\n\u0417\u0430\u043f\u043e\u0447\u043d\u0435\u0442\u0435<\/th>\nTypical effective range<\/th>\n\u041c\u0430\u043a\u0441\u0438\u043c\u0430\u043b\u043d\u043e<\/th>\n\u0411\u0435\u043b\u0435\u0436\u043a\u0438<\/th>\n<\/tr>\n<\/thead>\n
    \u0413\u043e\u043b\u044f\u043c\u043e \u0434\u0435\u043f\u0440\u0435\u0441\u0438\u0432\u043d\u043e \u0440\u0430\u0437\u0441\u0442\u0440\u043e\u0439\u0441\u0442\u0432\u043e<\/td>\n75 mg\/day with food<\/td>\n150–225 mg\/day<\/td>\n375 mg\/day<\/td>\nIncrease by 75 mg every 2 weeks<\/td>\n<\/tr>\n
    GAD, social anxiety, panic<\/td>\n37.5–75 mg\/day<\/td>\n75–225 mg\/day<\/td>\n225 mg\/day<\/td>\nSlower up-titration in panic to avoid early agitation<\/td>\n<\/tr>\n
    Elderly \/ hepatic \/ renal impairment<\/td>\n37.5 mg\/day<\/td>\nUp to 75–150 mg with caution<\/td>\n\u2014<\/td>\nReduce by 25–50% in moderate hepatic impairment<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Mechanism by Dose<\/h2>\n

    Pharmacology shifts as dose climbs<\/h2>\n\n\n\n\n\n\n\n\n
    \u0414\u043d\u0435\u0432\u043d\u0430 \u0434\u043e\u0437\u0430<\/th>\nPharmacology<\/th>\nClinical relevance<\/th>\n<\/tr>\n<\/thead>\n
    37.5–75 mg<\/td>\nPredominantly serotonergic (SSRI-like)<\/td>\nUseful as a starting \/ sub-therapeutic dose for tolerability<\/td>\n<\/tr>\n
    75–150 mg<\/td>\nMostly serotonergic with emerging noradrenergic activity<\/td>\nLower end of antidepressant efficacy range<\/td>\n<\/tr>\n
    150–225 mg<\/td>\nCombined SERT + NET inhibition (true SNRI)<\/td>\nStandard effective dose for most adults; full SNRI benefit<\/td>\n<\/tr>\n
    225–375 mg (MDD only)<\/td>\nStrong SERT + NET inhibition<\/td>\nUsed in treatment-resistant depression; BP and cardiac monitoring required<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    \u0421\u0442\u0440\u0430\u043d\u0438\u0447\u043d\u0438 \u0435\u0444\u0435\u043a\u0442\u0438<\/h2>\n

    \u0427\u0435\u0441\u0442\u043e, \u0443\u0441\u0442\u043e\u0439\u0447\u0438\u0432\u0438 \u0438 \u0440\u0435\u0434\u043a\u0438 \u0441\u0442\u0440\u0430\u043d\u0438\u0447\u043d\u0438 \u0435\u0444\u0435\u043a\u0442\u0438<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
    \u0427\u0435\u0441\u0442\u043e\u0442\u0430<\/th>\n\u0415\u0444\u0435\u043a\u0442<\/th>\n\u0411\u0435\u043b\u0435\u0436\u043a\u0438 \/ \u0443\u043f\u0440\u0430\u0432\u043b\u0435\u043d\u0438\u0435<\/th>\n<\/tr>\n<\/thead>\n
    \u0427\u0435\u0441\u0442\u043e \u0441\u0440\u0435\u0449\u0430\u043d\u0438<\/td>\nNausea (dose-dependent)<\/td>\nTake with food; usually subsides over 1–2 weeks<\/td>\n<\/tr>\n
    \u0427\u0435\u0441\u0442\u043e \u0441\u0440\u0435\u0449\u0430\u043d\u0438<\/td>\n\u0413\u043b\u0430\u0432\u043e\u0431\u043e\u043b\u0438\u0435, \u0437\u0430\u043c\u0430\u044f\u043d\u043e\u0441\u0442<\/td>\nTransient; adequate hydration<\/td>\n<\/tr>\n
    \u0427\u0435\u0441\u0442\u043e \u0441\u0440\u0435\u0449\u0430\u043d\u0438<\/td>\n\u0411\u0435\u0437\u0441\u044a\u043d\u0438\u0435 \u0438\u043b\u0438 \u0441\u044a\u043d\u043b\u0438\u0432\u043e\u0441\u0442<\/td>\nOften dose in the morning if activating<\/td>\n<\/tr>\n
    \u0427\u0435\u0441\u0442\u043e \u0441\u0440\u0435\u0449\u0430\u043d\u0438<\/td>\nDry mouth, constipation, sweating<\/td>\nSweating may persist; can be marked<\/td>\n<\/tr>\n
    \u0427\u0435\u0441\u0442\u043e \u0441\u0440\u0435\u0449\u0430\u043d\u0438<\/td>\n\u0421\u0435\u043a\u0441\u0443\u0430\u043b\u043d\u0430 \u0434\u0438\u0441\u0444\u0443\u043d\u043a\u0446\u0438\u044f<\/td>\nSimilar prevalence to SSRIs<\/td>\n<\/tr>\n
    \u041f\u043e-\u0440\u044f\u0434\u043a\u043e \u0441\u0440\u0435\u0449\u0430\u043d\u043e<\/td>\nIncreased blood pressure (dose-dependent)<\/td>\nCheck BP at baseline and periodically; significant rise above 225 mg\/day in 5–10% — may need dose reduction or switch<\/td>\n<\/tr>\n
    \u041f\u043e-\u0440\u044f\u0434\u043a\u043e \u0441\u0440\u0435\u0449\u0430\u043d\u043e<\/td>\nIncreased pulse, palpitations<\/td>\nCaution in patients with cardiac disease<\/td>\n<\/tr>\n
    \u041f\u043e-\u0440\u044f\u0434\u043a\u043e \u0441\u0440\u0435\u0449\u0430\u043d\u043e<\/td>\nWeight changes (modest)<\/td>\nLess weight gain than paroxetine or mirtazapine<\/td>\n<\/tr>\n
    \u0420\u044f\u0434\u043a\u043e<\/td>\n\u0425\u0438\u043f\u043e\u043d\u0430\u0442\u0440\u0438\u0435\u043c\u0438\u044f (SIADH)<\/td>\n\u0412\u044a\u0437\u0440\u0430\u0441\u0442\u043d\u0438\u0442\u0435 \u0445\u043e\u0440\u0430 \u0441\u0430 \u043d\u0430\u0439-\u0438\u0437\u043b\u043e\u0436\u0435\u043d\u0438 \u043d\u0430 \u0440\u0438\u0441\u043a<\/td>\n<\/tr>\n
    \u0420\u044f\u0434\u043a\u043e<\/td>\nBleeding risk<\/td>\nCaution with NSAIDs, anticoagulants<\/td>\n<\/tr>\n
    \u0420\u044f\u0434\u043a\u043e<\/td>\n\u0421\u0435\u0440\u043e\u0442\u043e\u043d\u0438\u043d\u043e\u0432 \u0441\u0438\u043d\u0434\u0440\u043e\u043c<\/td>\nSee interactions<\/td>\n<\/tr>\n
    \u0420\u044f\u0434\u043a\u043e<\/td>\nMydriasis \/ acute angle-closure glaucoma<\/td>\nCaution in narrow-angle glaucoma<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    \u0421\u0438\u043d\u0434\u0440\u043e\u043c \u043d\u0430 \u043f\u0440\u0435\u043a\u044a\u0441\u0432\u0430\u043d\u0435 \u043d\u0430 \u043b\u0435\u0447\u0435\u043d\u0438\u0435\u0442\u043e<\/h2>\n

    Venlafaxine has a short half-life<\/strong> (parent ~5 h; active metabolite desvenlafaxine ~11 h). Discontinuation symptoms are severe and rapid<\/strong>, second only to paroxetine: brain zaps, dizziness, nausea, sweating, irritability, insomnia, vivid dreams, flu-like aches. Often appear within 24–48 hours of a missed dose.<\/p>\n

    Mandatory slow taper<\/strong>: reduce by 75 mg every 2–4 weeks; below 75 mg use the smallest available capsule and consider every-other-day or hyperbolic tapering. Never stop abruptly. Patients on long-term venlafaxine often spend months on tapering — this is normal.<\/p>\n

    \u041b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u0438 \u0432\u0437\u0430\u0438\u043c\u043e\u0434\u0435\u0439\u0441\u0442\u0432\u0438\u044f<\/h2>\n

    \u0410\u0431\u0441\u043e\u043b\u044e\u0442\u043d\u0438 \u043a\u043e\u043d\u0442\u0440\u0430\u0438\u043d\u0434\u0438\u043a\u0430\u0446\u0438\u0438<\/strong>: MAOIs, linezolid, methylene blue. 14-day washout.<\/p>\n

    Serotonergic interactions<\/strong>: triptans, tramadol, pethidine, dextromethorphan, St John’s wort, lithium — serotonin syndrome risk.<\/p>\n

    CYP2D6 substrate<\/strong>: levels rise with strong CYP2D6 inhibitors (paroxetine, fluoxetine, bupropion, quinidine). Consider dose reduction.<\/p>\n

    Bleeding risk<\/strong>: NSAIDs, aspirin, warfarin, DOACs.<\/p>\n

    Cardiac and Overdose Considerations<\/h2>\n

    Venlafaxine is more dangerous in overdose than SSRIs<\/strong>: cardiac conduction abnormalities, QT prolongation, seizures, and serotonin syndrome have been reported. Provide only short supplies to patients at acute suicide risk. Pre-existing significant cardiac disease, recent MI, or uncontrolled hypertension are relative contraindications.<\/p>\n

    \u0427\u0435\u0441\u0442\u043e \u0437\u0430\u0434\u0430\u0432\u0430\u043d\u0438 \u0432\u044a\u043f\u0440\u043e\u0441\u0438<\/h2>\n

    How long does Venpad XR take to work?<\/h3>\n

    Anxiety symptoms often improve in 2–3 weeks; mood response in MDD typically appears at 4–6 weeks. Patients on sub-therapeutic doses (< 150 mg) may need dose escalation before seeing full benefit.<\/p>\n

    Why does the dose matter so much for venlafaxine?<\/h3>\n

    Below 150 mg\/day, venlafaxine acts mostly like an SSRI — norepinephrine reuptake inhibition appears only at higher doses. Patients who don’t respond at 75 mg often respond once titrated to 150 mg or above.<\/p>\n

    Will Venpad XR raise my blood pressure?<\/h3>\n

    Possibly — venlafaxine causes dose-dependent BP increases. Below 150 mg the effect is small; above 225 mg, 5–10% of patients see clinically significant increases. BP should be monitored at baseline and after dose escalations.<\/p>\n

    Can I stop Venpad XR abruptly?<\/h3>\n

    No — venlafaxine has one of the worst discontinuation syndromes in the antidepressant class (brain zaps, dizziness, nausea, sweating). Mandatory taper, often over months for long-term users.<\/p>\n

    Is Venpad XR safe in pregnancy?<\/h3>\n

    Limited data — not the first-choice antidepressant in pregnancy. Sertraline is preferred. Late-third-trimester exposure carries a small risk of neonatal adaptation syndrome and persistent pulmonary hypertension of the newborn.<\/p>\n

    Does Venpad XR cause weight gain?<\/h3>\n

    Less than paroxetine or mirtazapine. Some patients see modest weight changes; others lose weight from initial GI side effects. Less metabolic burden than antipsychotics.<\/p>\n

    Can I drink alcohol on Venpad XR?<\/h3>\n

    Light, occasional alcohol is generally tolerated. Heavy alcohol use worsens depression \/ anxiety, increases sedation, and is implicated in disinhibited behaviour.<\/p>\n

    \u041a\u0430\u043a\u0432\u043e \u0434\u0430 \u043d\u0430\u043f\u0440\u0430\u0432\u044f, \u0430\u043a\u043e \u043f\u0440\u043e\u043f\u0443\u0441\u043d\u0430 \u0434\u043e\u0437\u0430?<\/h3>\n

    Take it as soon as you remember unless close to the next dose. Withdrawal symptoms can begin within 24–48 hours of a missed dose — do not skip multiple doses.<\/p>\n

    How is Venpad XR different from duloxetine or desvenlafaxine?<\/h3>\n

    All are SNRIs. Duloxetine has a different binding profile (more SNRI even at lower doses, hepatic concerns), is also approved for diabetic neuropathy and fibromyalgia. Desvenlafaxine is the active metabolite of venlafaxine — bypasses CYP2D6 metabolism, more predictable plasma levels.<\/p>\n

    How should Venpad XR be stored?<\/h3>\n

    Store at 15–30 °C in the original blister packaging, away from moisture and sunlight. Keep out of reach of children — venlafaxine overdose is medically significant.<\/p>\n

    \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0430 \u043a\u043b\u0430\u0443\u0437\u0430:<\/strong> \u0418\u043d\u0444\u043e\u0440\u043c\u0430\u0446\u0438\u044f\u0442\u0430 \u043d\u0430 \u0442\u0430\u0437\u0438 \u0441\u0442\u0440\u0430\u043d\u0438\u0446\u0430 \u0435 \u043f\u0440\u0435\u0434\u043d\u0430\u0437\u043d\u0430\u0447\u0435\u043d\u0430 \u0437\u0430 \u0432\u044a\u0437\u0440\u0430\u0441\u0442\u043d\u0438, \u0438\u0437\u043f\u043e\u043b\u0437\u0432\u0430\u0449\u0438 \u043f\u0440\u0435\u0434\u043f\u0438\u0441\u0430\u043d\u0438 \u043f\u0441\u0438\u0445\u0438\u0430\u0442\u0440\u0438\u0447\u043d\u0438 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0430, \u0438 \u043d\u0435 \u0435 \u0437\u0430\u043c\u0435\u0441\u0442\u0438\u0442\u0435\u043b \u043d\u0430 \u0438\u043d\u0434\u0438\u0432\u0438\u0434\u0443\u0430\u043b\u043d\u0438\u044f \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438 \u0433\u0440\u0438\u0436\u0438. \u0410\u043d\u0442\u0438\u0434\u0435\u043f\u0440\u0435\u0441\u0430\u043d\u0442\u0438\u0442\u0435, \u0430\u043d\u0442\u0438\u043f\u0441\u0438\u0445\u043e\u0442\u0438\u0446\u0438\u0442\u0435 \u0438 \u0441\u0432\u044a\u0440\u0437\u0430\u043d\u0438\u0442\u0435 \u0441 \u0442\u044f\u0445 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0430 \u043c\u043e\u0433\u0430\u0442 \u0434\u0430 \u0432\u0437\u0430\u0438\u043c\u043e\u0434\u0435\u0439\u0441\u0442\u0432\u0430\u0442 \u0441 \u0434\u0440\u0443\u0433\u0438 \u043c\u0435\u0434\u0438\u043a\u0430\u043c\u0435\u043d\u0442\u0438, \u0430\u043b\u043a\u043e\u0445\u043e\u043b \u0438 \u0441\u044a\u0449\u0435\u0441\u0442\u0432\u0443\u0432\u0430\u0449\u0438 \u0437\u0430\u0431\u043e\u043b\u044f\u0432\u0430\u043d\u0438\u044f. \u041e\u0431\u0441\u044a\u0436\u0434\u0430\u0439\u0442\u0435 \u0432\u0441\u044f\u043a\u043e \u043d\u043e\u0432\u043e \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e, \u043f\u0440\u043e\u043c\u044f\u043d\u0430 \u0432 \u0434\u043e\u0437\u0430\u0442\u0430 \u0438\u043b\u0438 \u043f\u043b\u0430\u043d\u0438\u0440\u0430\u043d\u043e \u043f\u0440\u0435\u0443\u0441\u0442\u0430\u043d\u043e\u0432\u044f\u0432\u0430\u043d\u0435 \u0441 \u043a\u0432\u0430\u043b\u0438\u0444\u0438\u0446\u0438\u0440\u0430\u043d \u043b\u0435\u043a\u0430\u0440. \u0410\u043a\u043e \u0438\u0437\u043f\u0438\u0442\u0432\u0430\u0442\u0435 \u0441\u0430\u043c\u043e\u0443\u0431\u0438\u0439\u0441\u0442\u0432\u0435\u043d\u0438 \u043c\u0438\u0441\u043b\u0438, \u043c\u0430\u043d\u0438\u044f, \u0442\u0435\u0436\u043a\u0430 \u0430\u043a\u0430\u0442\u0438\u0437\u0438\u044f, \u043f\u0440\u0438\u0437\u043d\u0430\u0446\u0438 \u043d\u0430 \u0441\u0435\u0440\u043e\u0442\u043e\u043d\u0438\u043d\u043e\u0432 \u0441\u0438\u043d\u0434\u0440\u043e\u043c (\u0432\u0438\u0441\u043e\u043a\u0430 \u0442\u0435\u043c\u043f\u0435\u0440\u0430\u0442\u0443\u0440\u0430, \u043e\u0431\u044a\u0440\u043a\u0432\u0430\u043d\u0435, \u043c\u0443\u0441\u043a\u0443\u043b\u043d\u0430 \u0440\u0438\u0433\u0438\u0434\u043d\u043e\u0441\u0442, \u0431\u044a\u0440\u0437 \u0441\u044a\u0440\u0434\u0435\u0447\u0435\u043d \u0440\u0438\u0442\u044a\u043c) \u0438\u043b\u0438 \u043d\u0435\u0432\u0440\u043e\u043b\u0435\u043f\u0442\u0438\u0447\u0435\u043d \u0437\u043b\u043e\u043a\u0430\u0447\u0435\u0441\u0442\u0432\u0435\u043d \u0441\u0438\u043d\u0434\u0440\u043e\u043c, \u043f\u043e\u0442\u044a\u0440\u0441\u0435\u0442\u0435 \u0441\u043f\u0435\u0448\u043d\u0430 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0430 \u043f\u043e\u043c\u043e\u0449 \u043d\u0435\u0437\u0430\u0431\u0430\u0432\u043d\u043e.<\/div>\n

    <\/p>\n

    \u0421\u0432\u044a\u0440\u0437\u0430\u043d\u0438 \u0430\u043b\u0442\u0435\u0440\u043d\u0430\u0442\u0438\u0432\u0438<\/h3>\n

    \u0414\u0440\u0443\u0433\u0438 \u043f\u0440\u043e\u0434\u0443\u043a\u0442\u0438 \u0432 \u0425\u0440\u043e\u043d\u0438\u0447\u043d\u0438 \u0437\u0430\u0431\u043e\u043b\u044f\u0432\u0430\u043d\u0438\u044f<\/strong> \u043a\u043e\u0438\u0442\u043e \u043a\u043b\u0438\u0435\u043d\u0442\u0438\u0442\u0435 \u0441\u044a\u0449\u043e \u0440\u0430\u0437\u0433\u043b\u0435\u0436\u0434\u0430\u0442:<\/p>\n